LUCD logo

Lucid Diagnostics Inc. Common Stock


LUCD: Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.


Show LUCD Financials

Consumer Interest
SEC Filings

Recent trades of LUCD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by LUCD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of LUCD in WallStreetBets Daily Discussion


Recent insights relating to LUCD

CNBC Recommendations

Recent picks made for LUCD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LUCD

Corporate Flights

Flights by private jets registered to LUCD